Knowledge (XXG)

Digoxin immune fab

Source 📝

516:
chronic digoxin poisoning. Data also support outcomes of acute digoxin poisoning without use of anti‐digoxin Fab. A case series of 147 patients showed that not all cases of acute digoxin overdose require anti‐digoxin Fab, nor should anti‐digoxin Fab dose be calculated based on ingested dose. In contrast, a higher mortality (7.6%) was noted in a case series of acute and chronic digoxin and digitoxin poisoning despite Fab being used first line. Further, a retrospective case‐controlled study of chronic digoxin poisoning did not observe a beneficial effect of anti‐digoxin Fab on mortality. An RCT (n = 66) in yellow oleander poisoning showed an early improvement in cardiac rhythm and hyperkalaemia from anti‐digoxin Fab, prompting early termination of the trial. It was not powered to detect a change in mortality and no deaths were noted. As with all foreign proteins, anaphylaxis, serum sickness or febrile reactions are a source of concern, especially with repeated administration. These reactions appear uncommon for example, in a study of 717 adults where only six patients (0.8%) exhibited any evidence of allergic response. Nevertheless, theoretically, patients previously dependent upon the inotropic effects of digoxin could develop heart failure and hypokalaemia could result within 1–5 hours, owing to intracellular shifts of potassium, as the effects of digoxin are reversed. Patients who require redigitalization must wait for the complexes to be eliminated from the body by the kidneys, this taking 2–3 days with normal renal function. Unfortunately, fab fragments interfere with both fluorescence excitation transfer immunoassays and radioimmunoassays for digoxin. This means that serum drug levels cannot be monitored until the drug-antibody complexes are cleared from the circulation.
594:. DigiFab is manufactured and distributed by BTG international Inc. under U.S. License No. 186. DigiFab is a sterile, lyophilized preparation of digoxin-immune ovine Fab (monovalent) immunoglobulin fragments. It is prepared by isolating the immunoglobulin fraction of the ovine serum, digesting it with papain and isolating the digoxin-specific Fab fragments by affinity chromatography. These antibody fragments have a molecular weight of approximately 46,000 Da. Each vial of DigiFab, which will bind approximately 0.5 mg digoxin, contains 40 mg of digoxin immune Fab, 75 mg (approx) of mannitol USP, and 2 mg (approx) sodium acetate USP as a buffering agent. The product contains no preservatives and is intended for intravenous administration. 615: 530: 676:
per 38 mg vial and US $ 786 per 40 mg vial respectively. After GSK discontinued Digibind sale in USA in 2011, the AWP of DigiFab increases by 15% to US $ 903 per 40 mg vial. AWP of DigiFab has continued to increase as much as 54% occurring in March 2014 to US $ 2,370 per 40 mg vial. However, the cost may vary depending on wholesaler contractor manufacturer rebates.
29: 675:
Price increase was reported to range from US $ 380 to US $ 750 during 2013 for digoxin-Fab. However, these price increases are not reflective of the United States average AWP for digoxin-Fab as it represents Australian costs converted to US. Prior to 2011, Digibind and DigiFab pricing was US $ 797
515:
Case series have reported benefits from anti‐digoxin Fab, but data regarding the response in acute or chronic poisoning are conflicting. Recent observational data support an effect in acute poisoning, but efficacy in chronic poisoning be minimally effective in alleviating cardiac toxicities in
600:
A patent to use digoxin immunoglobulins C07k16/44 as a regulator of the preeclamptic/eclamptic patient's sodium/potassium ATPase activity was approved in 2003 to Charles David Adair under application number WO2004011028A1.
403:. Digoxin toxicity can emerge during long-term therapy as well as after an overdose. It can occur even when the serum digoxin concentration is within the therapeutic range when one of the following is present: 135: 90: 343: 507:
It works by binding to the digoxin, rendering it unable to bind to its action sites on target cells. The complexes accumulate in the blood and are expelled by the kidney.
54: 693: 499:
into Fab and Fc fragments) should not use ovine digoxin immune fab. Because it is relatively new, no drug interaction studies have been performed yet.
597:
Digibind is manufactured by GlaxoSmithkline, SpA, Parma Italy under US License No. 129. It’s distributed by GSK, Research Triangle park, NC 27709.
1602: 969: 636: 551: 662: 577: 1378: 797: 1501: 207: 120: 640: 555: 827: 1619: 1203: 625: 540: 384: 644: 629: 559: 544: 1554: 1411: 1103: 828:"Digibind, DigiFab (digoxin immune FAB (Antidote)) dosing, indications, interactions, adverse effects, and more" 1607: 1331: 1050: 962: 72: 1581: 1547: 269: 1437: 1349: 749:"Analysis of the use of digoxin immune fab for the treatment of non-life-threatening digoxin toxicity" 1025: 1002: 164: 83: 1646: 1281: 1576: 1486: 1422: 1225: 955: 778: 722: 480: 473: 1481: 1471: 1396: 1388: 1341: 1318: 1296: 933: 884: 770: 44: 1528: 1354: 1254: 923: 915: 874: 866: 760: 400: 285: 177: 146: 1586: 1541: 1158: 388: 154: 1613: 1535: 1476: 1447: 1371: 1285: 1148: 991: 928: 903: 879: 854: 1640: 1506: 1272: 1166: 1083: 805: 782: 64: 1366: 1236: 1075: 982: 103: 98: 20: 694:"Prescription medicines: registration of new chemical entities in Australia, 2014" 1496: 1467: 1452: 1326: 1138: 1098: 1060: 614: 529: 469: 461: 79: 1522: 1457: 1427: 1211: 1191: 1181: 1065: 1010: 408: 324: 244: 1176: 1133: 1118: 1088: 1035: 919: 488: 465: 187: 58: 888: 774: 592:
as an antidote to treat a life-threatening overdose of digoxin or digitoxin
937: 1406: 1244: 1186: 1171: 1123: 1113: 1040: 1015: 978: 765: 748: 496: 372: 224: 233: 1360: 1292: 380: 368: 870: 1568: 492: 484: 260: 192: 947: 28: 1128: 376: 472:
potassium levels and could precipitate dangerous and even fatal
951: 853:
Roberts DM, Gallapatthy G, Dunuwille A, Chan BS (March 2016).
747:
DiDomenico RJ, Walton SM, Sanoski CA, Bauman JL (April 2000).
608: 523: 129: 855:"Pharmacological treatment of cardiac glycoside poisoning" 753:
Journal of Cardiovascular Pharmacology and Therapeutics
350: 416:
digoxin level > 4 ng/ml if chronic ingestion
1567: 1514: 1466: 1436: 1405: 1387: 1340: 1317: 1310: 1271: 1253: 1235: 1224: 1200: 1157: 1097: 1074: 1049: 1024: 1001: 990: 419:
digoxin level > 10 ng/ml if acute ingestion
323: 284: 279: 259: 243: 223: 198: 186: 176: 163: 153: 145: 119: 114: 89: 71: 53: 43: 38: 426:Side effects of digoxin immune fab may occur: 963: 904:"Diagnosis and treatment of digoxin toxicity" 464:as this drug, while reversing the effects of 436:swelling of the lips, tongue, face, or throat 8: 19: 643:. Unsourced material may be challenged and 558:. Unsourced material may be challenged and 511:Regulatory information and clinical studies 172:15 hours for DigiFab, 23 hours for Digibind 1314: 1232: 998: 970: 956: 948: 802:LITFL • Life in the Fast Lane Medical Blog 717: 715: 479:The patient must be closely monitored for 387:(DDMA). Its brand names include Digibind ( 27: 927: 902:Lip GY, Metcalfe MJ, Dunn FG (May 1993). 878: 764: 663:Learn how and when to remove this message 578:Learn how and when to remove this message 859:British Journal of Clinical Pharmacology 483:, and anyone allergic to sheep protein, 379:that have already been immunized with a 685: 495:extracts (papain is used to cleave the 232: 212: 698:Therapeutic Goods Administration (TGA) 422:potassium > 5 mEq/L and symptomatic 18: 268: 63: 7: 641:adding citations to reliable sources 556:adding citations to reliable sources 102: 14: 613: 528: 302: 296: 367:is an antidote for overdose of 314: 308: 290: 215:Anti-digoxin antibody fragment 1: 385:digoxindicarboxymethoxylamine 908:Postgraduate Medical Journal 723:"digoxin immune Fab (ovine)" 33:Bottle of digoxin immune fab 1663: 796:Nickson C (11 July 2014). 280:Chemical and physical data 1597: 1555:Prednisolone/promethazine 1536:Methylthioninium chloride 407:Hemodynamically unstable 391:) and DigiFab (BTG plc). 365:digoxin-specific antibody 340: 203: 65:Consumer Drug Information 26: 920:10.1136/pgmj.69.811.337 1548:Potassium permanganate 1204:neuromuscular blockade 468:, will further reduce 1350:4-Dimethylaminophenol 520:Intellectual property 1438:Paracetamol toxicity 1282:direct Xa inhibitors 1003:Alcohol intoxication 766:10.1053/XV.2000.5590 637:improve this section 552:improve this section 808:on 20 February 2016 474:cardiac arrhythmias 433:difficult breathing 138:(Prescription only) 23: 16:Pharmaceutical drug 1624:Never to phase III 1421:Primary alcohols: 1379:Sodium thiosulfate 1263:Digoxin immune fab 798:"Digoxin Toxicity" 605:Commercial aspects 481:anaphylactic shock 371:. It is made from 361:Digoxin immune fab 178:Duration of action 21:Digoxin immune fab 1634: 1633: 1563: 1562: 1397:Calcium gluconate 1389:Hydrofluoric acid 1342:Cyanide poisoning 1319:Arsenic poisoning 1306: 1305: 1220: 1219: 871:10.1111/bcp.12814 673: 672: 665: 588: 587: 580: 456:Contraindications 358: 357: 133: 1654: 1529:Potassium iodide 1355:Hydroxocobalamin 1315: 1255:Digoxin toxicity 1233: 999: 972: 965: 958: 949: 942: 941: 931: 914:(811): 337–339. 899: 893: 892: 882: 850: 844: 843: 841: 839: 824: 818: 817: 815: 813: 804:. Archived from 793: 787: 786: 768: 744: 738: 737: 735: 733: 719: 710: 709: 707: 705: 690: 668: 661: 657: 654: 648: 617: 609: 590:DigiFab is used 583: 576: 572: 569: 563: 532: 524: 413:End organ damage 401:digoxin toxicity 354: 353: 346: 335: 333: 316: 310: 304: 298: 292: 272: 236: 168: 131: 128: 106: 67: 49:Digibind, others 31: 24: 22: 1662: 1661: 1657: 1656: 1655: 1653: 1652: 1651: 1637: 1636: 1635: 1630: 1629: 1614:Clinical trials 1593: 1587:Syrup of ipecac 1559: 1542:oxidizing agent 1510: 1462: 1441:(Acetaminophen) 1440: 1432: 1413: 1412:Ethylene glycol 1410: 1401: 1383: 1336: 1302: 1267: 1249: 1227: 1216: 1202: 1196: 1159:Opioid overdose 1153: 1105: 1104:Organophosphate 1102: 1093: 1070: 1052: 1045: 1027: 1020: 993: 986: 976: 946: 945: 901: 900: 896: 852: 851: 847: 837: 835: 826: 825: 821: 811: 809: 795: 794: 790: 746: 745: 741: 731: 729: 721: 720: 713: 703: 701: 692: 691: 687: 682: 669: 658: 652: 649: 634: 618: 607: 584: 573: 567: 564: 549: 533: 522: 513: 505: 458: 451:lightheadedness 399:It is used for 397: 389:GlaxoSmithKline 375:fragments from 349: 347: 344:(what is this?) 341: 331: 329: 319: 313: 307: 301: 295: 275: 255: 239: 219: 216: 211: 210: 166: 155:Onset of action 147:Pharmacokinetic 141: 110: 74: 34: 17: 12: 11: 5: 1660: 1658: 1650: 1649: 1639: 1638: 1632: 1631: 1628: 1627: 1626: 1625: 1622: 1611: 1605: 1599: 1598: 1595: 1594: 1592: 1591: 1590: 1589: 1579: 1577:Copper sulfate 1573: 1571: 1565: 1564: 1561: 1560: 1558: 1557: 1552: 1551: 1550: 1538: 1533: 1532: 1531: 1518: 1516: 1512: 1511: 1509: 1504: 1499: 1494: 1492: 1491: 1490: 1484: 1479: 1464: 1463: 1461: 1460: 1455: 1450: 1448:Acetylcysteine 1444: 1442: 1434: 1433: 1431: 1430: 1425: 1418: 1416: 1403: 1402: 1400: 1399: 1393: 1391: 1385: 1384: 1382: 1381: 1376: 1375: 1374: 1372:Sodium nitrite 1369: 1357: 1352: 1346: 1344: 1338: 1337: 1335: 1334: 1329: 1323: 1321: 1312: 1308: 1307: 1304: 1303: 1301: 1300: 1289: 1286:Andexanet alfa 1277: 1275: 1273:Anticoagulants 1269: 1268: 1266: 1265: 1259: 1257: 1251: 1250: 1248: 1247: 1241: 1239: 1230: 1222: 1221: 1218: 1217: 1215: 1214: 1208: 1206: 1198: 1197: 1195: 1194: 1189: 1184: 1179: 1174: 1169: 1163: 1161: 1155: 1154: 1152: 1151: 1149:Cholinesterase 1143: 1142: 1141: 1136: 1126: 1121: 1116: 1110: 1108: 1095: 1094: 1092: 1091: 1086: 1080: 1078: 1072: 1071: 1069: 1068: 1063: 1057: 1055: 1051:Benzodiazepine 1047: 1046: 1044: 1043: 1038: 1032: 1030: 1022: 1021: 1019: 1018: 1013: 1007: 1005: 996: 988: 987: 977: 975: 974: 967: 960: 952: 944: 943: 894: 865:(3): 488–495. 845: 819: 788: 739: 711: 700:. 21 June 2022 684: 683: 681: 678: 671: 670: 621: 619: 612: 606: 603: 586: 585: 536: 534: 527: 521: 518: 512: 509: 504: 501: 457: 454: 453: 452: 449: 446: 443: 440: 437: 434: 431: 424: 423: 420: 417: 414: 411: 396: 393: 373:immunoglobulin 356: 355: 338: 337: 327: 321: 320: 317: 311: 305: 299: 293: 288: 282: 281: 277: 276: 274: 273: 265: 263: 257: 256: 254: 253: 249: 247: 241: 240: 238: 237: 229: 227: 221: 220: 218: 217: 214: 206: 205: 204: 201: 200: 196: 195: 190: 184: 183: 180: 174: 173: 170: 161: 160: 157: 151: 150: 143: 142: 140: 139: 125: 123: 117: 116: 112: 111: 109: 108: 95: 93: 87: 86: 77: 75:administration 69: 68: 61: 51: 50: 47: 41: 40: 36: 35: 32: 15: 13: 10: 9: 6: 4: 3: 2: 1659: 1648: 1645: 1644: 1642: 1623: 1621: 1618: 1617: 1615: 1612: 1609: 1606: 1604: 1601: 1600: 1596: 1588: 1585: 1584: 1583: 1580: 1578: 1575: 1574: 1572: 1570: 1566: 1556: 1553: 1549: 1546: 1545: 1544: 1543: 1539: 1537: 1534: 1530: 1527: 1526: 1525: 1524: 1520: 1519: 1517: 1513: 1508: 1507:Prussian blue 1505: 1503: 1500: 1498: 1495: 1493: 1488: 1485: 1483: 1480: 1478: 1475: 1474: 1473: 1469: 1465: 1459: 1456: 1454: 1451: 1449: 1446: 1445: 1443: 1439: 1435: 1429: 1426: 1424: 1420: 1419: 1417: 1415: 1408: 1404: 1398: 1395: 1394: 1392: 1390: 1386: 1380: 1377: 1373: 1370: 1368: 1365: 1364: 1363: 1362: 1358: 1356: 1353: 1351: 1348: 1347: 1345: 1343: 1339: 1333: 1330: 1328: 1325: 1324: 1322: 1320: 1316: 1313: 1309: 1298: 1294: 1290: 1287: 1283: 1279: 1278: 1276: 1274: 1270: 1264: 1261: 1260: 1258: 1256: 1252: 1246: 1243: 1242: 1240: 1238: 1234: 1231: 1229: 1223: 1213: 1210: 1209: 1207: 1205: 1199: 1193: 1190: 1188: 1185: 1183: 1180: 1178: 1175: 1173: 1170: 1168: 1167:Diprenorphine 1165: 1164: 1162: 1160: 1156: 1150: 1147: 1144: 1140: 1137: 1135: 1132: 1131: 1130: 1127: 1125: 1122: 1120: 1117: 1115: 1112: 1111: 1109: 1107: 1100: 1096: 1090: 1087: 1085: 1084:Physostigmine 1082: 1081: 1079: 1077: 1073: 1067: 1064: 1062: 1059: 1058: 1056: 1054: 1048: 1042: 1039: 1037: 1034: 1033: 1031: 1029: 1023: 1017: 1014: 1012: 1009: 1008: 1006: 1004: 1000: 997: 995: 989: 984: 980: 973: 968: 966: 961: 959: 954: 953: 950: 939: 935: 930: 925: 921: 917: 913: 909: 905: 898: 895: 890: 886: 881: 876: 872: 868: 864: 860: 856: 849: 846: 833: 829: 823: 820: 807: 803: 799: 792: 789: 784: 780: 776: 772: 767: 762: 758: 754: 750: 743: 740: 728: 727:www.glowm.com 724: 718: 716: 712: 699: 695: 689: 686: 679: 677: 667: 664: 656: 646: 642: 638: 632: 631: 627: 622:This section 620: 616: 611: 610: 604: 602: 598: 595: 593: 582: 579: 571: 561: 557: 553: 547: 546: 542: 537:This section 535: 531: 526: 525: 519: 517: 510: 508: 502: 500: 498: 494: 490: 486: 482: 477: 475: 471: 467: 463: 460:Avoid use in 455: 450: 447: 444: 441: 438: 435: 432: 429: 428: 427: 421: 418: 415: 412: 410: 406: 405: 404: 402: 394: 392: 390: 386: 382: 378: 374: 370: 366: 362: 352: 345: 339: 328: 326: 322: 289: 287: 283: 278: 271: 270:ChEMBL1201588 267: 266: 264: 262: 258: 251: 250: 248: 246: 242: 235: 231: 230: 228: 226: 222: 213: 209: 202: 197: 194: 191: 189: 185: 181: 179: 175: 171: 169: 162: 158: 156: 152: 148: 144: 137: 127: 126: 124: 122: 118: 113: 105: 100: 97: 96: 94: 92: 88: 85: 81: 78: 76: 70: 66: 62: 60: 56: 52: 48: 46: 42: 39:Clinical data 37: 30: 25: 1540: 1521: 1468:Toxic metals 1367:Amyl nitrite 1359: 1262: 1237:Beta blocker 1145: 1076:GHB overdose 911: 907: 897: 862: 858: 848: 836:. Retrieved 831: 822: 810:. Retrieved 806:the original 801: 791: 759:(2): 77–85. 756: 752: 742: 730:. Retrieved 726: 702:. Retrieved 697: 688: 674: 659: 653:January 2018 650: 635:Please help 623: 599: 596: 591: 589: 574: 568:January 2018 565: 550:Please help 538: 514: 506: 503:Pharmacology 478: 459: 442:skin redness 425: 398: 395:Medical uses 383:derivative, 364: 360: 359: 348:   342:   182:15 to 20 hrs 165:Elimination 121:Legal status 115:Legal status 1610:from market 1582:Ipecacuanha 1497:Dimercaprol 1453:Glutathione 1327:Dimercaprol 1226:Circulatory 1201:Reversal of 1139:Pralidoxime 1099:Nerve agent 1061:Cyprodenate 1026:Barbiturate 834:. WebMD LLC 732:8 September 462:hypokalemia 336: g·mol 199:Identifiers 80:IV infusion 45:Trade names 1647:Antitoxins 1523:iodine-131 1458:Methionine 1428:Fomepizole 1212:Sugammadex 1192:Naltrexone 1182:Nalorphine 1066:Flumazenil 1011:Metadoxine 680:References 409:arrhythmia 325:Molar mass 245:ChemSpider 208:IUPAC name 1620:Phase III 1608:Withdrawn 1414:poisoning 1297:Protamine 1177:Nalmefene 1146:see also: 1134:Obidoxime 1119:Biperiden 1106:poisoning 1089:SCH-50911 1041:Ethamivan 1036:Bemegride 979:Antidotes 624:does not 539:does not 489:bromelain 466:digitalis 188:Excretion 167:half-life 84:injection 73:Routes of 59:Drugs.com 1641:Category 1502:Edetates 1487:thallium 1407:Methanol 1332:Succimer 1291:against 1280:against 1245:Glucagon 1187:Naloxone 1172:Doxapram 1124:Diazepam 1114:Atropine 1053:overdose 1028:overdose 1016:Thiamine 889:26505271 832:Medscape 783:33064518 775:11150387 704:10 April 497:antibody 445:wheezing 351:(verify) 225:DrugBank 91:ATC code 1482:mercury 1472:cadmium 1423:Ethanol 1361:nitrite 1293:heparin 992:Nervous 938:8346128 929:2399830 880:4767196 838:24 July 812:24 July 645:removed 630:sources 560:removed 545:sources 439:itching 381:digoxin 369:digoxin 286:Formula 234:DB00076 107:) 101: ( 99:V03AB24 1603:WHO-EM 1569:Emetic 1228:system 1129:Oximes 994:system 936:  926:  887:  877:  781:  773:  493:papaya 485:papain 261:ChEMBL 193:Kidney 159:30 min 134: 1515:Other 1311:Other 983:V03AB 779:S2CID 491:, or 470:serum 448:cough 430:hives 377:sheep 1477:lead 934:PMID 885:PMID 840:2017 814:2017 771:PMID 734:2020 706:2023 628:any 626:cite 543:any 541:cite 300:3223 294:2085 252:none 149:data 55:AHFS 924:PMC 916:doi 875:PMC 867:doi 761:doi 639:by 554:by 363:or 334:.88 332:301 312:672 306:553 104:WHO 1643:: 1616:: 932:. 922:. 912:69 910:. 906:. 883:. 873:. 863:81 861:. 857:. 830:. 800:. 777:. 769:. 755:. 751:. 725:. 714:^ 696:. 487:, 476:. 330:47 318:16 136:S4 130:AU 82:, 1489:) 1470:( 1409:/ 1299:) 1295:( 1288:) 1284:( 1101:/ 985:) 981:( 971:e 964:t 957:v 940:. 918:: 891:. 869:: 842:. 816:. 785:. 763:: 757:5 736:. 708:. 666:) 660:( 655:) 651:( 647:. 633:. 581:) 575:( 570:) 566:( 562:. 548:. 315:S 309:O 303:N 297:H 291:C 132:: 57:/

Index


Trade names
AHFS
Drugs.com
Consumer Drug Information
Routes of
administration

IV infusion
injection
ATC code
V03AB24
WHO
Legal status
S4
Pharmacokinetic
Onset of action
Elimination half-life
Duration of action
Excretion
Kidney
IUPAC name
DrugBank
DB00076
ChemSpider
ChEMBL
ChEMBL1201588
Formula
Molar mass
(what is this?)
(verify)
digoxin

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.